Ptt

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Acronym for partial thromboplastin time (PTT). Screening test for defects of the endogenous coagulation system (factors XV, XIV, XII, XI, IX, VIII) and the common final coagulation pathway (FX, V, II, I). Prolonged PTT serves as a screening test for lupus anticoagulant (see below phospholipid-antibody syndrome, see below lupus erythematosus, systemic)

General informationThis section has been translated automatically.

  • Norm: 20-38 seconds.
  • PTT extended:
  • PTT shortened:
    • Hypercoagulability
    • Thrombocytosis (increase in platelet factor 4).

IndicationThis section has been translated automatically.

  • Suspected hemorrhagic diathesis (screening test for endogenous system)
  • Monitoring therapy with heparin
  • Monitoring of substitution therapy for haemophilia A and haemophilia B
  • preoperative screening.

Note(s)This section has been translated automatically.

For therapeutic reasons, heparin low-dose therapy should be prolonged to 1.5-2.0 times its original duration! Low molecular weight heparins (NMH) hardly prolong PTT due to their anti-Xa activity!

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer